Back to search results

Understanding Force Feedback in da Vinci 5 Robotic Surgery

This study aims to understand how useful force feedback instruments are during surgeries performed with the da Vinci 5 robot. Researchers will look at the amount of force applied to tissues during operations for conditions like hernias (when an organ pushes through a weak spot in muscle or tissue), colorectal (related to the colon or rectum), thoracic (related to the chest), and gynecologic (related to the female reproductive system) issues. You may be able to join if you are 22 years or older, have an ASA score of 3 or less (a measure of your physical health before surgery), and are already scheduled for multi-port robotic surgery using the da Vinci 5 with force feedback instruments. The main goal is to measure the force applied to tissue during your surgery. The study is currently unclear on its recruitment status.

Study design
This is an observational study, meaning researchers will watch and record information during your surgery. It plans to include 200 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06879912

A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot

Recruiting
Not specifiedAges 22+Observational
Intuitive Surgical
~200 participants
Updated 2026-02-25 on ClinicalTrials.gov

At a glance

Recruiting sites
5 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To assess the force imparted on the tissue by force feedback instruments.
Measured over Intra-operative

Conditions

Hernia, Inguinal
Hernia, Ventral
Colorectal
Thoracic
Gynecologic
Partial Nephrectomy

Explore related trials

Colorectal CarcinomaInguinal HerniaMalignant Female Reproductive System NeoplasmRenal Cell CarcinomaThoracic NeoplasmVentral Hernia

Where it's being run

5 sites across 5 states
Florida1
Georgia1
Illinois1
Ohio1
Texas1

Who to contact

Smruthi Srinivasa Murthy
[email protected]
682-552-6131
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Subject receiving an emergent procedure
Subject planned to undergo major concomitant surgery for the treatment of a different medical condition than was originally planned
Subject with previous ipsilateral surgery (open, endoscopic or robotic) with the same surgical indication
Subject with past or ongoing medical conditions (for example: inflammatory bowel disease) which, in the judgment of the Investigator, puts them at high risk for surgery and not appropriate for the study
Subject is pregnant or suspected to be pregnant or breastfeeding
Subject has any other condition or personal circumstance that, in the judgment of the Investigator, might interfere with the collection of complete quality data
Subject is currently participating in or has participated in a study of an investigational agent or a significant risk investigational device study within the past 6 months
Subject belongs to a vulnerable population.
Subject is contraindicated for anesthesia or surgery.
Subject has had previous neoadjuvant therapy, previous chemotherapy, immunotherapy, and/or radiation therapy for the treatment of the cancer to be resected within the past 6 months
Subject with hemodynamic or respiratory instability, which precludes the Investigator from performing the RAS.
Subject in whom inadequate visualization makes a minimally invasive approach not feasible, as determined from the investigator assessment prior to docking the robot.
Subject with adhesions, scarring and disease status in the body which in the opinion of the investigator limits the ability to perform the minimally invasive procedure.

What this trial measures

  • To assess the force imparted on the tissue by force feedback instruments.Intra-operative